Will MR-linac Prove A Turning Point For Radiotherapy And For Elekta?
This article was originally published in Clinica
Elekta last year set off on what it hoped was a path to recovery, after reporting significantly below-par results for fiscal 2015 under the watch of the then-CEO Niklas Savander. The Swedish cancer treatment specialist unveiled a comprehensive action program and underwent a major executive reshuffle, including the appointment of a new head, Richard Hausmann, formerly chief of GE Healthcare’s MR business.
Register for our free email digests: